(Q26781747)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26482189%20AND%20SRC:MED&resulttype=core&format=json

Advanced Drug Delivery Reviews

5 June 2020

language of work or name

English

0 references

publication date

1 December 2015

0 references

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26482189%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

volume

95

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26482189%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

page(s)

50-55

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26482189%20AND%20SRC:MED&resulttype=core&format=json

Microvesicle-shuttled miR-130b reduces fat deposition in recipient primary cultured porcine adipocytes by inhibiting PPAR-g expression

5 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.ADDR.2015.10.002

7 January 2021

Exosomes as a potential tool for a specific delivery of functional molecules

1 reference

https://api.crossref.org/works/10.1016%2FJ.ADDR.2015.10.002

7 January 2021

Highlights of a new type of intercellular communication: microvesicle-based information transfer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ADDR.2015.10.002

7 January 2021

Biogenesis of extracellular vesicles (EV): exosomes, microvesicles, retrovirus-like vesicles, and apoptotic bodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.ADDR.2015.10.002

7 January 2021

Exosome delivered anticancer drugs across the blood-brain barrier for brain cancer therapy in Danio rerio

1 reference

https://api.crossref.org/works/10.1016%2FJ.ADDR.2015.10.002

7 January 2021

Activation-induced internalization differs for the tetraspanins CD9 and Tspan8: Impact on tumor cell motility.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ADDR.2015.10.002

7 January 2021

Toward tailored exosomes: the exosomal tetraspanin web contributes to target cell selection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ADDR.2015.10.002

7 January 2021

A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ADDR.2015.10.002

7 January 2021

In Vivo imaging reveals extracellular vesicle-mediated phenocopying of metastatic behavior

1 reference

https://api.crossref.org/works/10.1016%2FJ.ADDR.2015.10.002

7 January 2021

Exosomes as immunotheranostic nanoparticles.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ADDR.2015.10.002

7 January 2021

Visualization and in vivo tracking of the exosomes of murine melanoma B16-BL6 cells in mice after intravenous injection

1 reference

https://api.crossref.org/works/10.1016%2FJ.ADDR.2015.10.002

7 January 2021

Microvesicles and exosomes: opportunities for cell-derived membrane vesicles in drug delivery

1 reference

https://api.crossref.org/works/10.1016%2FJ.ADDR.2015.10.002

7 January 2021

Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: a new approach for drug delivery

1 reference

https://api.crossref.org/works/10.1016%2FJ.ADDR.2015.10.002

7 January 2021

Biodistribution and delivery efficiency of unmodified tumor-derived exosomes

1 reference

https://api.crossref.org/works/10.1016%2FJ.ADDR.2015.10.002

7 January 2021

Possibilities and limitations of current technologies for quantification of biological extracellular vesicles and synthetic mimics.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ADDR.2015.10.002

7 January 2021

Exosomes as drug delivery vehicles for Parkinson's disease therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.ADDR.2015.10.002

7 January 2021

Curcumin-primed exosomes mitigate endothelial cell dysfunction during hyperhomocysteinemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.ADDR.2015.10.002

7 January 2021

Ultrafiltration with size-exclusion liquid chromatography for high yield isolation of extracellular vesicles preserving intact biophysical and functional properties

1 reference

https://api.crossref.org/works/10.1016%2FJ.ADDR.2015.10.002

7 January 2021

Micromanaging of tumor metastasis by extracellular vesicles.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ADDR.2015.10.002

7 January 2021

GP120-specific exosome-targeted T cell-based vaccine capable of stimulating DC- and CD4(+) T-independent CTL responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.ADDR.2015.10.002

7 January 2021

A strategy of antigen incorporation into exosomes: comparing cross-presentation levels of antigens delivered by engineered exosomes and by lentiviral virus-like particles.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ADDR.2015.10.002

7 January 2021

PEGylation, successful approach to drug delivery

1 reference

https://api.crossref.org/works/10.1016%2FJ.ADDR.2015.10.002

7 January 2021

Determination of exosome concentration in solution using surface plasmon resonance spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FJ.ADDR.2015.10.002

7 January 2021

Liposomes: from a clinically established drug delivery system to a nanoparticle platform for theranostic nanomedicine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ADDR.2015.10.002

7 January 2021

Bioinspired exosome-mimetic nanovesicles for targeted delivery of chemotherapeutics to malignant tumors

1 reference

https://api.crossref.org/works/10.1016%2FJ.ADDR.2015.10.002

7 January 2021

Dynamic biodistribution of extracellular vesicles in vivo using a multimodal imaging reporter

1 reference

https://api.crossref.org/works/10.1016%2FJ.ADDR.2015.10.002

7 January 2021

Impact of nanotechnology on drug delivery.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ADDR.2015.10.002

7 January 2021

Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming

1 reference

https://api.crossref.org/works/10.1016%2FJ.ADDR.2015.10.002

7 January 2021

Phase I clinical trial of autologous ascites-derived exosomes combined with GM-CSF for colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.ADDR.2015.10.002

7 January 2021

A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes

1 reference

https://api.crossref.org/works/10.1016%2FJ.ADDR.2015.10.002

7 January 2021

Microvesicle-mediated RNA molecule delivery system using monocytes/macrophages

1 reference

https://api.crossref.org/works/10.1016%2FJ.ADDR.2015.10.002

7 January 2021

Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain

1 reference

https://api.crossref.org/works/10.1016%2FJ.ADDR.2015.10.002

7 January 2021

Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.ADDR.2015.10.002

7 January 2021

Delivery of Functional Anti-miR-9 by Mesenchymal Stem Cell-derived Exosomes to Glioblastoma Multiforme Cells Conferred Chemosensitivity

1 reference

https://api.crossref.org/works/10.1016%2FJ.ADDR.2015.10.002

7 January 2021

Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes

1 reference

https://api.crossref.org/works/10.1016%2FJ.ADDR.2015.10.002

7 January 2021

Breast-cancer-secreted miR-122 reprograms glucose metabolism in premetastatic niche to promote metastasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.ADDR.2015.10.002

7 January 2021

Choroid plexus transcytosis and exosome shuttling deliver folate into brain parenchyma

1 reference

https://api.crossref.org/works/10.1016%2FJ.ADDR.2015.10.002

7 January 2021

Brain metastatic cancer cells release microRNA-181c-containing extracellular vesicles capable of destructing blood-brain barrier

1 reference

https://api.crossref.org/works/10.1016%2FJ.ADDR.2015.10.002

7 January 2021

Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes

1 reference

https://api.crossref.org/works/10.1016%2FJ.ADDR.2015.10.002

7 January 2021

Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET

1 reference

https://api.crossref.org/works/10.1016%2FJ.ADDR.2015.10.002

7 January 2021

Exosome-mediated delivery of siRNA in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.ADDR.2015.10.002

7 January 2021

Extracellular vesicles: biology and emerging therapeutic opportunities.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ADDR.2015.10.002

7 January 2021

Collection, storage, preservation, and normalization of human urinary exosomes for biomarker discovery

1 reference

https://api.crossref.org/works/10.1016%2FJ.ADDR.2015.10.002

7 January 2021

Macrophage immunomodulation by breast cancer-derived exosomes requires Toll-like receptor 2-mediated activation of NF-κB.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ADDR.2015.10.002

7 January 2021

Neutral sphingomyelinase 2 (nSMase2)-dependent exosomal transfer of angiogenic microRNAs regulate cancer cell metastasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.ADDR.2015.10.002

7 January 2021

Extracellular vesicles: exosomes, microvesicles, and friends

1 reference

https://api.crossref.org/works/10.1016%2FJ.ADDR.2015.10.002

7 January 2021

B lymphocytes secrete antigen-presenting vesicles

1 reference

https://api.crossref.org/works/10.1016%2FJ.ADDR.2015.10.002

7 January 2021

Exosome targeting of tumor antigens expressed by cancer vaccines can improve antigen immunogenicity and therapeutic efficacy

1 reference

https://api.crossref.org/works/10.1016%2FJ.ADDR.2015.10.002

7 January 2021

Exosomes released by melanoma cells prepare sentinel lymph nodes for tumor metastasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.ADDR.2015.10.002

7 January 2021

Therapeutic nanoparticles for drug delivery in cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.ADDR.2015.10.002

7 January 2021

Antileukaemia immunity: effect of exosomes against NB4 acute promyelocytic leukaemia cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.ADDR.2015.10.002

7 January 2021

Tumor-exosomes and leukocyte activation: an ambivalent crosstalk

1 reference

https://api.crossref.org/works/10.1016%2FJ.ADDR.2015.10.002

7 January 2021

Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.ADDR.2015.10.002

7 January 2021

A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.ADDR.2015.10.002

7 January 2021

Nonspecific CD4(+) T cells with uptake of antigen-specific dendritic cell-released exosomes stimulate antigen-specific CD8(+) CTL responses and long-term T cell memory

1 reference

https://api.crossref.org/works/10.1016%2FJ.ADDR.2015.10.002

7 January 2021

Exosome release and low pH belong to a framework of resistance of human melanoma cells to cisplatin

1 reference

https://api.crossref.org/works/10.1016%2FJ.ADDR.2015.10.002

7 January 2021

As we wait: coping with an imperfect nomenclature for extracellular vesicles

1 reference

https://api.crossref.org/works/10.1016%2FJ.ADDR.2015.10.002

7 January 2021

Cavin-1/PTRF alters prostate cancer cell-derived extracellular vesicle content and internalization to attenuate extracellular vesicle-mediated osteoclastogenesis and osteoblast proliferation

1 reference

https://api.crossref.org/works/10.1016%2FJ.ADDR.2015.10.002

7 January 2021

Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ADDR.2015.10.002

7 January 2021

Biodistribution of mesenchymal stem cell-derived extracellular vesicles in a model of acute kidney injury monitored by optical imaging

1 reference

https://api.crossref.org/works/10.1016%2FJ.ADDR.2015.10.002

7 January 2021

Novel exosome-targeted CD4+ T cell vaccine counteracting CD4+25+ regulatory T cell-mediated immune suppression and stimulating efficient central memory CD8+ CTL responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.ADDR.2015.10.002

7 January 2021

10.1016/J.ADDR.2015.10.002

Identifiers

DOI

2 references

Consolidated OpenCitations Corpus – April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26482189%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

1 reference

Consolidated OpenCitations Corpus – April 2017

2 references

Consolidated OpenCitations Corpus – April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26482189%20AND%20SRC:MED&resulttype=core&format=json